A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

2008305 citationsJournal Articlebronze Open Access

Authors

Prophylactic lamivudine use, but not therapeutic use, reduces the incidence and severity of chemotherapy-related HBV reactivation in NHL patients.

Good health and well-being

Published in: Hepatology

Volume 47, Issue 3, pp. 844-853

Field-Weighted Citation Impact: 14.22